Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY38.99 CNY
Change Today +0.88 / 2.31%
Volume 10.5M
300147 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

xiangxue pharmaceutical co-a (300147) Snapshot

Open
CNY38.00
Previous Close
CNY38.11
Day High
CNY39.99
Day Low
CNY36.12
52 Week High
05/26/15 - CNY44.34
52 Week Low
12/30/14 - CNY15.15
Market Cap
19.9B
Average Volume 10 Days
15.1M
EPS TTM
CNY0.41
Shares Outstanding
509.6M
EX-Date
05/22/15
P/E TM
94.1x
Dividend
CNY0.14
Dividend Yield
0.35%
Current Stock Chart for XIANGXUE PHARMACEUTICAL CO-A (300147)

Related News

No related news articles were found.

xiangxue pharmaceutical co-a (300147) Related Businessweek News

No Related Businessweek News Found

xiangxue pharmaceutical co-a (300147) Details

Xiangxue Pharmaceutical Co., Ltd. is engaged in the development, production, and distribution of Chinese patent medicines in China and internationally. The company offers Chinese medicines, western medicines, medical devices, and health products, as well as beverages. It also offers antiviral oral liquids for the prevention and treatment of cold under the brand name of Xiangxue; and indigowoad root granules. The company offers its products in the form of tablets, capsules, granules, oral liquids, aerosols, and others. Xiangxue Pharmaceutical Co., Ltd. was founded in 1997 and is based in Guangzhou, China.

Founded in 1997

xiangxue pharmaceutical co-a (300147) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

xiangxue pharmaceutical co-a (300147) Key Developments

Xiangxue Pharmaceutical Co., Ltd.(SZSE:300147) added to Shenzhen Stock Exchange Component A Share Index

Xiangxue Pharmaceutical Co., Ltd. has been added to Shenzhen Stock Exchange Component A Share Index.

Xiangxue Pharmaceutical Co., Ltd.(SZSE:300147) added to Shenzhen Stock Exchange Component Index

Xiangxue Pharmaceutical Co., Ltd. has been added to Shenzhen Stock Exchange Component Index.

Xiangxue Pharmaceutical Co., Ltd. Announces Final Cash Dividend for the Year 2014, Payable on May 22, 2015

Xiangxue Pharmaceutical Co., Ltd. announced that 2014 final distribution plan to be implemented (A shares) of cash dividend per 10 shares (tax included) of CNY 1.35000000. Net cash dividend per 10 shares after tax of CNY 1.21500000. Record date is May 21, 2015. Ex-date May 22, 2015. The dividend is payable on May 22, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300147:CH CNY38.99 CNY +0.88

300147 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300147.
View Industry Companies
 

Industry Analysis

300147

Industry Average

Valuation 300147 Industry Range
Price/Earnings 97.2x
Price/Sales 12.2x
Price/Book 10.6x
Price/Cash Flow 99.4x
TEV/Sales 11.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XIANGXUE PHARMACEUTICAL CO-A, please visit www.xphcn.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.